Five undervalued stocks including CleanSpark, Sanofi, Uber, Macy's and e.l.f. Beauty combine discounted valuations with strong analyst buy ratings for 2026.

Shifting gears, it turns out that 2025 was a slightly off year for drug approvals by the US Food and Drug Administration. A ...

As demand accelerates for faster, more accessible diagnostic imaging across the Middle East and Africa (MEA), Cairo-based ...

Jollibee Foods Corp plans to spin off its international operations and list the new unit as an independent company on a U.S.

Jollibee Foods Corp. announces plans to spin off its international operations for a U.S. listing by 2027 while maintaining ...

Earendil Labs will receive up to $160 million in upfront and near-term payments tied to early program achievements. The total potential value of the collaboration, including upfront, development, and ...

Epithelioma Treatment Market to reach USD 13.1 billion by 2035, driven by rising skin cancer cases and growing adoption of ...

Enable Injections closed a $215 million Series C financing in January 2022 led by Magnetar Capital, including Sanofi and multiple additional new institutional investors. Enable received significant ...

Dow Jones Top Company Headlines at 5 AM ET: Sanofi Says FDA Agrees to Review Diabetes Drug Age Range | Simulation ... The company said the regulator accepted a priority review to potentially expand ...

Global High Potency API CDMOs Market OverviewThe global High Potency API CDMOs market is projected to achieve strong single-digit growth by 2027, driven by a rapid surge in demand for oncology ...

Sanofi’s Tzield has been accepted for priority review by the U.S. Food and Drug Administration to expand its use to children aged one year and older with stage 2 type 1 diabetes. The submission is ...

Orano has been chosen by the US Department of Energy to receive up to 900 million US dollars in funding to support the construction of a new uranium enrichment facility in the United States, ...